AG Coffman Notifies Eligible Colorado Residents of Extension to Submit Claims for Provigil Settlement | Attorney General - State of Colorado

AG Coffman Notifies Eligible Colorado Residents of Extension to Submit Claims for Provigil Settlement

To receive settlement funds, claims must be filed by Wednesday, June 25

DENVER – Attorney General Cynthia H. Coffman is notifying Colorado residents that the deadline has been extended to file claims related to a multistate settlement for consumers who paid for Provigil or modafinil between June 24, 2006 and March 31, 2012.  The new deadline to file claims or object to the settlement is June 25, 2017.

Modafinil is approved by the federal Food and Drug Administration (FDA) to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder.

In August 2016, Colorado and 47 other state attorneys general announced the settlement with biopharmaceutical company Cephalon, Inc. and its affiliated companies, including Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc., resolving allegations that the companies engaged in unlawful "pay-for-delay" anticompetitive conduct involving the patent exclusivity for Provigil. The original press release from November 17, 2016 can be found here.

The settlement included $35 million to compensate eligible consumers who may have been harmed by the alleged conduct.  Originally, the deadline for consumers to file claims or object to the settlement was Thursday, April 13, 2017.  At the State’s request, the Court granted an extension of the time to file a claim or object to the settlement.  The new deadline is June 25, 2017.

For more information or to obtain a claim form, visit www.StateAGProvigilSettlement.com or call 1-877-236-1413.